Douglas S. Tyler

14.2k total citations · 1 hit paper
293 papers, 9.5k citations indexed

About

Douglas S. Tyler is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Douglas S. Tyler has authored 293 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Oncology, 96 papers in Surgery and 57 papers in Molecular Biology. Recurrent topics in Douglas S. Tyler's work include Cutaneous Melanoma Detection and Management (85 papers), Pancreatic and Hepatic Oncology Research (55 papers) and Immunotherapy and Immune Responses (40 papers). Douglas S. Tyler is often cited by papers focused on Cutaneous Melanoma Detection and Management (85 papers), Pancreatic and Hepatic Oncology Research (55 papers) and Immunotherapy and Immune Responses (40 papers). Douglas S. Tyler collaborates with scholars based in United States, Japan and Canada. Douglas S. Tyler's co-authors include Theodore N. Pappas, Bryan M. Clary, Rebekah R. White, Hilliard F. Seigler, Herbert I. Hurwitz, Michael A. Morse, Scott K. Pruitt, Brian G. Czito, Christopher G. Willett and Georgia M. Beasley and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Douglas S. Tyler

286 papers receiving 9.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extent of Surgery for Papillary Thyroid Cancer Is Not Associated With Survival

2014 304 citations Douglas S. Tyler et al. profile →

Peers

Countries citing papers authored by Douglas S. Tyler

Since Specialization

Citations

This map shows the geographic impact of Douglas S. Tyler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas S. Tyler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas S. Tyler more than expected).

Fields of papers citing papers by Douglas S. Tyler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas S. Tyler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas S. Tyler. The network helps show where Douglas S. Tyler may publish in the future.

Co-authorship network of co-authors of Douglas S. Tyler

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas S. Tyler. A scholar is included among the top collaborators of Douglas S. Tyler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas S. Tyler. Douglas S. Tyler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Spatial biology analysis reveals B cell follicles in secondary lymphoid structures may regulate anti-tumor responses at initial melanoma diagnosis 2022 ·Frontiers in Immunology ·(unknown), Georgia M. Beasley, Kristen E. Rhodin, Norma E. Farrow, Douglas S. Tyler, David Boczkowski, Rami N. Al‐Rohil, Eda K. Holl, Smita K. Nair	3
2	How much time is enough? Sentinel lymph node mapping time depends on the radiotracer agent 2021 ·Journal of Surgical Oncology ·(unknown), Norma E. Farrow, (unknown), (unknown), Charles Intenzo, (unknown), Douglas S. Tyler, Adam C. Berger, Georgia M. Beasley	2
3	Ipilimumab and Radiation in Patients with High-risk Resected or Regionally Advanced Melanoma 2020 ·Clinical Cancer Research ·April K.S. Salama, Manisha Palta, Christel Rushing, M. Angélica Selim, Kristen N. Linney, Brian G. Czito, David S. Yoo, Brent A. Hanks, Georgia M. Beasley, Paul J. Mosca, (unknown), (unknown), John S. Yi, Kent J. Weinhold, Douglas S. Tyler, Walter T. Lee, David M. Brizel	4
4	Transient activation of tumoral DNA damage tolerance pathway coupled with immune checkpoint blockade exerts durable tumor regression in mouse melanoma 2020 ·Pigment Cell & Melanoma Research ·Ming Zhuo, (unknown), Douglas S. Tyler, Ella W. Englander	4
5	Hypoxia potentiates the capacity of melanoma cells to evade cisplatin and doxorubicin cytotoxicity via glycolytic shift 2020 ·FEBS Open Bio ·Ming Zhuo, (unknown), Douglas S. Tyler, Ella W. Englander	7
6	It depends on your perspective: Resident satisfaction with operative experience 2016 ·The American Journal of Surgery ·Jean‐Marc Perone, Grant T. Fankhauser, Deepak Adhikari, Hemalkumar B. Mehta, (unknown), Douglas S. Tyler, Kimberly M. Brown	18
7	Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy 2015 ·Cancer Immunology Research ·Alisha Holtzhausen, Fei Zhao, Kathy S. Evans, (unknown), Ciriana Orabona, Douglas S. Tyler, Brent A. Hanks	144
8	Chemotherapeutic Agents Subvert Tumor Immunity by Generating Agonists of Platelet-Activating Factor 2014 ·Cancer Research ·Ravi P. Sahu, (unknown), Kathleen A. Harrison, Matheus Ferracini, Christopher E. Touloukian, Mohammed Al‐Hassani, (unknown), Mathew Loesch, Robert C. Murphy, Sandra K. Althouse, Susan M. Perkins, Paul J. Speicher, Douglas S. Tyler, Raymond L. Konger, Jeffrey B. Travers	36
9	The role of clinical care pathways: an experience with distal pancreatectomy 2014 ·Journal of Surgical Research ·Daniel P. Nussbaum, Kara Penne, Paul J. Speicher, Sandra S. Stinnett, Alexander Perez, Rebekah R. White, Bryan M. Clary, Douglas S. Tyler, Dan G. Blazer	12
10	Immunotherapy Following Regional Chemotherapy Treatment of Advanced Extremity Melanoma 2014 ·Annals of Surgical Oncology ·(unknown), Georgia M. Beasley, Paul J. Speicher, Paul J. Mosca, Michael A. Morse, Brent A. Hanks, April K.S. Salama, Douglas S. Tyler	8
11	Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit Melanoma 2012 ·Clinical Cancer Research ·Ryan S. Turley, Andrew N. Fontanella, James C. Padussis, (unknown), Yoshihiro Tokuhisa, Eugenia H. Cho, Gabi Hanna, Georgia M. Beasley, Christina K. Augustine, Mark W. Dewhirst, Douglas S. Tyler	48
12	Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy 2010 ·Molecular Cancer Therapeutics ·Christina K. Augustine, (unknown), Sin‐Ho Jung, Patricia A. Zipfel, Jin Soo Yoo, Yasunori Yoshimoto, M. Angélica Selim, James L. Burchette, Georgia M. Beasley, Nicole McMahon, James C. Padussis, Scott K. Pruitt, Francis Ali‐Osman, Douglas S. Tyler	35
13	Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma 2010 ·Molecular Cancer Therapeutics ·Christina K. Augustine, Sin‐Ho Jung, Insuk Sohn, Jin Soo Yoo, Yasunori Yoshimoto, John A. Olson, Henry S. Friedman, Francis Ali‐Osman, Douglas S. Tyler	19
14	Genomic and Molecular Profiling Predicts Response to Temozolomide in Melanoma 2009 ·Clinical Cancer Research ·Christina K. Augustine, Jin Soo Yoo, Anil Potti, Yasunori Yoshimoto, Patricia A. Zipfel, Henry S. Friedman, Joseph R. Nevins, Francis Ali‐Osman, Douglas S. Tyler	74
15	Targeting N-Cadherin Enhances Antitumor Activity of Cytotoxic Therapies in Melanoma Treatment 2008 ·Cancer Research ·Christina K. Augustine, Yasunori Yoshimoto, (unknown), Patricia A. Zipfel, M. Angélica Selim, Phillip G. Febbo, Ann Marie Pendergast, William P. Peters, Douglas S. Tyler	85
16	Current Clinical and Research Approaches to Optimizing Regional Chemotherapy: Novel Strategies Generated Through a Better Understanding of Drug Pharmacokinetics, Drug Resistance, and the Development of Clinically Relevant Animal Models 2008 ·Surgical Oncology Clinics of North America ·Georgia M. Beasley, (unknown), Douglas S. Tyler	4
17	Concurrent Chemoradiotherapy in Resected Extrahepatic Cholangiocarcinoma 2008 ·International Journal of Radiation OncologyBiologyPhysics ·John W. Nelson, (unknown), Christopher G. Willett, Douglas S. Tyler, Theodore N. Pappas, Bryan M. Clary, Herbert I. Hurwitz, Johanna C. Bendell, Michael A. Morse, Robert Clough, Brian G. Czito	114
18	Induction of Human Dendritic Cell Maturation Using Transfection with RNA Encoding a Dominant Positive Toll-Like Receptor 4 2004 ·The Journal of Immunology ·(unknown), Zeinab Abdel-Wahab, Jens Dannull, Smita K. Nair, Douglas S. Tyler, Eli Gilboa, Johannes Vieweg, Yehia Daaka, Scott K. Pruitt	52
19	Carcinoids of unknown origin: Comparative analysis with foregut, midgut, and hindgut carcinoids 1998 ·Surgery ·Paul M. Kirshbom, Aftab R. Kherani, Mark W. Onaitis, Jerome M. Feldman, Douglas S. Tyler	54
20	Interleukin-1 Production in Tumor Cells of Human Melanoma Surgical Specimens 1995 ·Journal of Interferon & Cytokine Research ·Douglas S. Tyler, (unknown), Mitchell J. Frederick, (unknown), (unknown), J. L. Smith, Omar Eton, Merrick I. Ross, Elizabeth A. Grimm	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact